BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allegaert K, Langhendries JP, van den Anker JN. Educational paper: Do we need neonatal clinical pharmacologists. Eur J Pediatr. 2012;Epub ahead of print. [PMID: 22588521 DOI: 10.1007/s00431-012-1734-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Begou O, Kontou A, Raikos N, Sarafidis K, Roilides E, Papadoyannis IN, Gika HG. An ultra-high pressure liquid chromatography-tandem mass spectrometry method for the quantification of teicoplanin in plasma of neonates. J Chromatogr B Analyt Technol Biomed Life Sci 2017;1047:215-22. [PMID: 26896312 DOI: 10.1016/j.jchromb.2016.01.042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
2 Allegaert K, van den Anker JN. Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol 2015;80:788-95. [PMID: 24862557 DOI: 10.1111/bcp.12430] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
3 Allegaert K. Tailored tools to improve pharmacotherapy in infants. Expert Opin Drug Metab Toxicol 2014;10:1069-78. [PMID: 24961300 DOI: 10.1517/17425255.2014.931937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
4 de Souza AS Jr, Dos Santos DB, Rey LC, Medeiros MG, Vieira MG, Coelho HLL. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study. BMC Pediatr 2016;16:13. [PMID: 26795213 DOI: 10.1186/s12887-016-0551-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
5 Kent A, Turner MA, Sharland M, Heath PT. Aminoglycoside toxicity in neonates: something to worry about? Expert Rev Anti Infect Ther 2014;12:319-31. [PMID: 24455994 DOI: 10.1586/14787210.2014.878648] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
6 Allegaert K. Neonates need tailored drug formulations. World J Clin Pediatr 2013;2:1-5. [PMID: 25254168 DOI: 10.5409/wjcp.v2.i1.1] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Grisafi D, Ceschi A, Sava G, Avalos Clerici V, Scaglione F. Reconsidering clinical pharmacology frameworks as a necessary strategy for improving the health care of patients: a systematic review. Eur J Clin Pharmacol 2018;74:1663-70. [PMID: 30008120 DOI: 10.1007/s00228-018-2511-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gao L, Xu H, Ye Q, Li S, Wang J, Mei Y, Niu C, Kang T, Chen C, Wang Y. Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions. Front Pharmacol 2020;11:552. [PMID: 32431611 DOI: 10.3389/fphar.2020.00552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
9 Allegaert K, Sherwin C. Neonates and medicines: a roadmap to further improve neonatal pharmaceutical care. Eur J Pediatr 2016;175:743-6. [PMID: 26744132 DOI: 10.1007/s00431-015-2686-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
10 Oualha M, Urien S, Spreux-Varoquaux O, Bordessoule A, D'Agostino I, Pouard P, Tréluyer JM. Pharmacokinetics, hemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children. Crit Care 2014;18:R23. [PMID: 24456639 DOI: 10.1186/cc13707] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
11 Souza A, Santos D, Fonseca S, Medeiros M, Batista L, Turner M, Coelho H. Toxic excipients in medications for neonates in Brazil. Eur J Pediatr 2014;173:935-45. [DOI: 10.1007/s00431-014-2272-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
12 Samardzic J, Allegaert K, Bajcetic M. Developmental pharmacology: A moving target. Int J Pharm 2015;492:335-7. [PMID: 25959118 DOI: 10.1016/j.ijpharm.2015.05.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Campino A, Arranz C, Unceta M, Rueda M, Sordo B, Pascual P, Lopez-de-Heredia I, Santesteban E. Medicine preparation errors in ten Spanish neonatal intensive care units. Eur J Pediatr 2016;175:203-10. [PMID: 26311566 DOI: 10.1007/s00431-015-2615-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
14 Fjalstad JW, Laukli E, van den Anker JN, Klingenberg C. High-dose gentamicin in newborn infants: is it safe? Eur J Pediatr 2014;173:489-95. [DOI: 10.1007/s00431-013-2194-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
15 Allegaert K. Pediatric clinical pharmacology: an introduction to a series of educational papers. Eur J Pediatr 2013;172:289-92. [DOI: 10.1007/s00431-012-1921-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Allegaert K, Fanos V, van den Anker JN, Laër S. Perinatal pharmacology. Biomed Res Int 2014;2014:101620. [PMID: 24822175 DOI: 10.1155/2014/101620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Kontou A, Sarafidis K, Roilides E. Antimicrobial dosing in neonates. Expert Rev Clin Pharmacol 2017;10:239-42. [PMID: 28067058 DOI: 10.1080/17512433.2017.1279968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Samardzic J, Turner MA, Bax R, Allegaert K. Neonatal medicines research: challenges and opportunities. Expert Opin Drug Metab Toxicol 2015;11:1041-52. [PMID: 25958820 DOI: 10.1517/17425255.2015.1046433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
19 Karpova EP, Kharina DV. [The possibilities for the rational pharmacotherapy of adenoiditis in the children]. Vestn Otorinolaringol 2016;81:73-6. [PMID: 27876743 DOI: 10.17116/otorino201681573-76] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Allegaert K. Clinical pharmacological studies in children: From exploratory towards confirmation driven methodology. World J Clin Pediatr. 2012;1:3-7. [PMID: 25254160 DOI: 10.5409/wjcp.v1.i2.3] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]